Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16Cl3N3O4S |
InChIKeyHAAITRDZHUANGT-FYZYNONXSA-N |
CAS Registry583057-49-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Candidiasis, Vulvovaginal | Phase 2 | FR | 11 Jun 2010 |
Phase 2 | 229 | (Placebo) | ghfzahblkm(vdbvzleehm) = xunosifaut ecmdsmdwpp (ybgrobihpu, pdazjgskcc - fjfmkjtaha) View more | - | 09 Oct 2013 | ||
placebo+arasertaconazole nitrate (Arasertaconazole Nitrate 150 mg) | ghfzahblkm(vdbvzleehm) = mowkjtnmxd ecmdsmdwpp (ybgrobihpu, tstoniiltx - nxxaugctgi) View more |